Marker Therapeutics, Inc.

Q4 2023 13F Holders

Symbol
MRKR
CUSIP
57055L206
Type
Equity
Class
COM NEW
Num filings
28
Total reported value, excl. options
$10.5 M
Manager Report Date Value ($000) Shares Option Type